Crossmark

CSAG2 is a cancer‐specific activator of SIRT1

Crossref DOI link: https://doi.org/10.15252/embr.202050912

Published Online: 2020-08-05

Published Print: 2020-09-03

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Yang, Xu https://orcid.org/0000-0002-0398-1436
Potts, Patrick Ryan https://orcid.org/0000-0002-2024-8885
Funding

Funding for this research was provided by:

American Cancer Society (181691010)
License Information

Version of Record valid from 2020-08-05
More Information

Publication History

Received: 2020-05-15

Accepted: 2020-07-10

Published: 2020-08-05